Charles K Gayer - Net Worth and Insider Trading
Charles K Gayer Net Worth
The estimated net worth of Charles K Gayer is at least $2 Million dollars as of 2024-11-05. Charles K Gayer is the Chief Commercial Officer of BioCryst Pharmaceuticals Inc and owns about 307,533 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $2 Million. Details can be seen in Charles K Gayer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles K Gayer has not made any transactions after 2024-05-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles K Gayer
Charles K Gayer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles K Gayer owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .
Click here to see the complete history of Charles K Gayer’s form 4 insider trades.
Insider Ownership Summary of Charles K Gayer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2024-05-13 | Vice President and CCO |
Charles K Gayer Latest Holdings Summary
Charles K Gayer currently owns a total of 1 stock. Charles K Gayer owns 307,533 shares of BioCryst Pharmaceuticals Inc (BCRX) as of May 13, 2024, with a value of $2 Million.
Latest Holdings of Charles K Gayer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2024-05-13 | 307,533 | 7.26 | 2,231,183 |
Holding Weightings of Charles K Gayer
Charles K Gayer Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles K Gayer has made a total of 2 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the acquisition of 30,000 shares on May 13, 2024, which cost Charles K Gayer around $164,100.
Insider Trading History of Charles K Gayer
- 1
Charles K Gayer Trading Performance
GuruFocus tracks the stock performance after each of Charles K Gayer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles K Gayer is 40.14%. GuruFocus also compares Charles K Gayer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles K Gayer within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles K Gayer's insider trading performs compared to the benchmark.
Performance of Charles K Gayer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.66 |  | | | | |
| Relative Return to S&P 500(%) | 6.59 | | | | | |
Charles K Gayer Ownership Network
Ownership Network List of Charles K Gayer
Ownership Network Relation of Charles K Gayer
Charles K Gayer Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
Charles K Gayer is the Vice President and CCO of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , VP & General Counsel & Corp Sec Alane P Barnes , and director & CEO Jon P Stonehouse .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, Charles K Gayer made 1 insider transaction in BioCryst Pharmaceuticals Inc (BCRX) with a net purchase of 30,000. Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 8,689 shares made by Machelle Sanders , a net sale of 7,866 shares made by Nancy J Hutson , and a net purchase of 36,300 shares made by Anthony Doyle .
In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,853 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 146,748 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
Charles K Gayer Mailing Address
Above is the net worth, insider trading, and ownership report for Charles K Gayer. You might contact Charles K Gayer via mailing address: 4505 Emperor Blvd., Suite 200, Durham Nc 27703.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
